Lydia Crowe, Director at Mtech Access, shares her experiences of returning to work during lockdown, following her maternity leave. With a background in health economics and medical writing, and more...
Read More
We recently welcomed Tina Teague to Mtech Access as a Senior Consultant in the NHS Insights and Interaction team. Tina has extensive experience across a range of sectors within the...
Read More
What changes can we expect to pharmacy, medicines management, and specialised commissioning in the new NHS? What will the introduction of medicines registers, as outlined in the Government’s Health and...
Read More
Nick Swart recently joined Mtech Access as a Senior Health Economist, following 5 years as a Research Associate in Health Economics at University College London. In this interview, Nick shares...
Read More
Are you looking to launch a new medical technology, medical or diagnostic device in the UK, Europe or North America? Would you like to know how health economic modelling could...
Read More
James Woolnough (Senior Medical Writer) shares his impressions of attending a virtual committee meeting at the National Institute for Health and Care Excellence (NICE) as a public observer. James is...
Read More
In this four-part series, Ines Tenente (Senior Consultant – Global Market Access) explores the various challenges facing orphan medicines entering the European market and suggests solutions that can help improve...
Read More
Are you wondering what integrated care will look like when the Health and Care White Paper proposals become a reality? Few are better placed than Dr John Ribchester to inform...
Read More
On 5th February 2021, the UK Government's draft Health and Care White Paper was leaked online. An authorised version was later published on 11th February 2021. The White Paper sets...
Read More
Challenges for orphan medicines entering the European market – Part 3: Economic evidence development
In this four-part series, Ines Tenente (Senior Consultant – Global Market Access) explores the various challenges facing orphan medicines entering the European market and suggests solutions that can help improve patient...
Read More